Headlines | WebDisclosure

Basculer en Français

10542	Companies
222640	Keywords
151744	Articles
117800	Press releases

BRIEF

published on 06/10/2026 at 00:05, 5 hours 33 minutes ago

Onco-Innovations Advances PNKP Inhibitor Technology Scaling

Clinical Trials Cancer Treatment Pharmaceutical Manufacturing Onco-Innovations API Development
BRIEF

published on 06/10/2026 at 00:05, 5 hours 33 minutes ago

Onco-Innovations fait progresser la mise à l'échelle de la technologie des inhibiteurs de PNKP

Essais Cliniques Traitement Du Cancer Fabrication Pharmaceutique Onco-Innovations Développement D'API
BRIEF

published on 06/10/2026 at 00:05, 5 hours 33 minutes ago

ABL Diagnostics : Informations sur les droits de vote et le capital

Euronext Paris Droits De Vote Actions Nominatives Biologie Moléculaire Capital Social ABL
BRIEF

published on 06/10/2026 at 00:05, 5 hours 33 minutes ago

ABL Diagnostics Discloses Voting and Share Information

Euronext Paris Share Capital Voting Rights Molecular Biology Double Voting
BRIEF

published on 06/10/2026 at 00:05, 5 hours 33 minutes ago

ABL Diagnostics: Information on voting rights and capital

Euronext Paris Voting Rights Registered Shares Molecular Biology ABL Share Capital
BRIEF

published on 06/10/2026 at 00:05, 5 hours 33 minutes ago

ABL Diagnostics divulgue des informations sur le vote et les actions

Euronext Paris Capital Social Droit De Vote Biologie Moléculaire Double Vote
PRESS RELEASE

published on 06/10/2026 at 00:00, 5 hours 38 minutes ago

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Onco-Innovations starts process development & scale-up activities for A83B4C63, advancing towards clinical trials. Collaboration with Dalton Pharma Services to optimize production processes and ensure regulatory readiness

Clinical Trials API Onco-Innovations Dalton Pharma Services Process Development
PRESS RELEASE

published on 06/10/2026 at 00:00, 5 hours 38 minutes ago

Modalités de mise à disposition des documents préparatoires à l'AG
ABL Diagnostics (ABLD) est une société internationale spécialisée dans les tests de biologie moléculaire innovants. Son siège est à Woippy. Elle est cotée sur Euronext Paris

Euronext Paris Biologie Moléculaire ABL Diagnostics Innovants Woippy
PRESS RELEASE

published on 06/10/2026 at 00:00, 5 hours 38 minutes ago

Terms of availability of the preparatory documents for the GM
ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers

Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
BRIEF

published on 06/09/2026 at 23:05, 6 hours 33 minutes ago

NXT Energy Solutions Inc. Reports Shareholder Meeting Outcomes

Voting Results Shareholder Meeting Director Elections Audit Appointment Share Resolutions

Accesswire

Published on 06/10/2026 at 00:00, 5 hours 38 minutes ago

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 6 hours 38 minutes ago

NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 7 hours 8 minutes ago

Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 7 hours 53 minutes ago

Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/09/2026 at 15:00, 14 hours 38 minutes ago

Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation

View all ACCESSWIRE

EQS Group

Published on 06/09/2026 at 22:55, 6 hours 43 minutes ago

JACOBS STEPS-UP AS 'OFFICIAL SPONSOR OF STAYING AWAKE' AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT
Published on 06/09/2026 at 22:35, 7 hours 3 minutes ago

Eurobattery Minerals publishes Annual Report 2025
Published on 06/09/2026 at 19:32, 10 hours 6 minutes ago

2CRSi SA: 2CRSi announces a €110 million sale of Godì Blackwell Ultra servers in Germany
Published on 06/09/2026 at 19:32, 10 hours 6 minutes ago

2CRSi SA: 2CRSi annonce une vente de 110 M€ de serveurs Godì Blackwell Ultra en Allemagne
Published on 06/09/2026 at 19:10, 10 hours 28 minutes ago

The 2026 Global Energy Prize shortlist released

Les Echos

Published on 06/09/2026 at 19:30, 10 hours 8 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 06/09/2026 at 19:30, 10 hours 8 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 11 hours 24 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/05/2026
Published on 06/09/2026 at 18:14, 11 hours 24 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 18:00, 11 hours 38 minutes ago

Klarsen : Report des résultats trimestriels et date de publication des comptes annuels

View all LES ECHOS COMFI WIRE